Golgi structural defect impairs glycosaminoglycan synthesis, sulfation, and secretion

Synthesis of glycosaminoglycans such as heparan sulfate (HS) and chondroitin sulfate (CS) occurs in the lumen of the Golgi but the relationship between Golgi structural integrity and glycosaminoglycan synthesis is not clear. In this study, we disrupted the Golgi structure by knocking out GRASP55 and GRASP65 and determined its effect on the synthesis, sulfation, and secretion of HS and CS. We found that GRASP depletion increased HS synthesis while decreasing CS synthesis in cells, altered HS and CS sulfation, and reduced both HS and CS secretion. Using proteomics, RNA-seq and biochemical approaches, we identified EXTL3, a key enzyme in the HS synthesis pathway, whose level is upregulated in GRASP knockout cells; while GalNacT1, an essential CS synthesis enzyme, is robustly reduced. In addition, we found that GRASP depletion decreased HS sulfation via the reduction of PAPSS2, a bifunctional enzyme in HS sulfation. Our study provides the first evidence that Golgi structural defect may significantly alter the synthesis and secretion of glycosaminoglycans.

[1]  A. Nesvizhskii,et al.  GRASP55 regulates mutant huntingtin unconventional secretion and aggregation , 2021 .

[2]  M. Plomann,et al.  An mTORC1-GRASP55 signaling axis controls unconventional secretion to reshape the extracellular proteome upon stress , 2021, Molecular cell.

[3]  K. Prydz,et al.  Proteoglycan synthesis in conserved oligomeric Golgi subunit deficient HEK293T cells is affected differently, depending on the lacking subunit , 2021, Traffic.

[4]  E. Yates,et al.  ER-Golgi dynamics of HS-modifying enzymes via vesicular trafficking is a critical prerequisite for the delineation of HS biosynthesis. , 2021, Carbohydrate polymers.

[5]  H. Lortat-Jacob,et al.  Heparan Sulfate Proteoglycans Biosynthesis and Post Synthesis Mechanisms Combine Few Enzymes and Few Core Proteins to Generate Extensive Structural and Functional Diversity , 2020, Molecules.

[6]  G. Lippens,et al.  3‐ O ‐Sulfation of Heparan Sulfate Enhances Tau Interaction and Cellular Uptake , 2019, Angewandte Chemie.

[7]  Erpan Ahat,et al.  New Insights Into the Golgi Stacking Proteins , 2019, Front. Cell Dev. Biol..

[8]  Erpan Ahat,et al.  Golgi Structure and Function in Health, Stress, and Diseases , 2019, Results and problems in cell differentiation.

[9]  Yi Xiang,et al.  GRASP depletion–mediated Golgi destruction decreases cell adhesion and migration via the reduction of α5β1 integrin , 2019, Molecular biology of the cell.

[10]  Yanzhuang Wang,et al.  GRASP55 facilitates autophagosome maturation under glucose deprivation , 2018, Molecular & cellular oncology.

[11]  E. Jokitalo,et al.  GRASP55 Senses Glucose Deprivation through O-GlcNAcylation to Promote Autophagosome-Lysosome Fusion. , 2018, Developmental cell.

[12]  E. Hanssen,et al.  The Golgi ribbon in mammalian cells negatively regulates autophagy by modulating mTOR activity , 2018, Journal of Cell Science.

[13]  J. Reiling,et al.  Golgi stress–induced transcriptional changes mediated by MAPK signaling and three ETS transcription factors regulate MCL1 splicing , 2018, Molecular biology of the cell.

[14]  D. Stephens,et al.  Giantin-knockout models reveal a feedback loop between Golgi function and glycosyltransferase expression , 2017, Journal of Cell Science.

[15]  M. Bekier,et al.  Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function , 2017, Molecular biology of the cell.

[16]  V. Malhotra,et al.  A diacidic motif determines unconventional secretion of wild-type and ALS-linked mutant SOD1 , 2017, The Journal of cell biology.

[17]  F. Sasarman,et al.  Biosynthesis of glycosaminoglycans: associated disorders and biochemical tests , 2016, Journal of Inherited Metabolic Disease.

[18]  M. Bekier,et al.  Golgi fragmentation in Alzheimer's disease , 2015, Front. Neurosci..

[19]  K. Prydz Determinants of Glycosaminoglycan (GAG) Structure , 2015, Biomolecules.

[20]  N. Maeda Proteoglycans and neuronal migration in the cerebral cortex during development and disease , 2015, Front. Neurosci..

[21]  L. Tabak,et al.  Galnt1 Is Required for Normal Heart Valve Development and Cardiac Function , 2015, PloS one.

[22]  K. Prydz,et al.  PAPST1 regulates sulfation of heparan sulfate proteoglycans in epithelial MDCK II cells. , 2015, Glycobiology.

[23]  M. H. Dunlop,et al.  Membrane adhesion dictates Golgi stacking and cisternal morphology , 2014, Proceedings of the National Academy of Sciences.

[24]  K. Aoki,et al.  Regulation of protein glycosylation and sorting by the Golgi matrix proteins GRASP55/65 , 2013, Nature Communications.

[25]  L. Claesson‐Welsh,et al.  Functional Overlap Between Chondroitin and Heparan Sulfate Proteoglycans During VEGF-Induced Sprouting Angiogenesis , 2012, Arteriosclerosis, thrombosis, and vascular biology.

[26]  Yumiko Yoshimura,et al.  Persistent cortical plasticity by upregulation of chondroitin 6-sulfation , 2012, Nature Neuroscience.

[27]  Min Goo Lee,et al.  Rescue of ΔF508-CFTR Trafficking via a GRASP-Dependent Unconventional Secretion Pathway , 2011, Cell.

[28]  Hebao Yuan,et al.  The Role of GRASP65 in Golgi Cisternal Stacking and Cell Cycle Progression , 2010, Traffic.

[29]  Yi Xiang,et al.  GRASP55 and GRASP65 play complementary and essential roles in Golgi cisternal stacking , 2010, The Journal of cell biology.

[30]  P. Park,et al.  Diverse functions of glycosaminoglycans in infectious diseases. , 2010, Progress in molecular biology and translational science.

[31]  Kai Griebenow,et al.  Effects of glycosylation on the stability of protein pharmaceuticals. , 2009, Journal of pharmaceutical sciences.

[32]  L. Kiesel,et al.  Changes in heparan sulfate are associated with delayed wound repair, altered cell migration, adhesion and contractility in the galactosyltransferase I (beta4GalT-7) deficient form of Ehlers-Danlos syndrome. , 2008, Human molecular genetics.

[33]  Yanzhuang Wang,et al.  Golgi Cisternal Unstacking Stimulates COPI Vesicle Budding and Protein Transport , 2008, PloS one.

[34]  B. Zabel,et al.  Expression profile of Papss2 (3′‐phosphoadenosine 5′‐phosphosulfate synthase 2) during cartilage formation and skeletal development in the mouse embryo , 2007, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  H. Maccioni,et al.  Cytoplasmic Tails of SialT2 and GalNAcT Impose Their Respective Proximal and Distal Golgi Localization , 2006, Traffic.

[36]  K. Ui-Tei,et al.  Molecular Cloning and Characterization of a Novel 3′-Phosphoadenosine 5′-Phosphosulfate Transporter, PAPST2* , 2006, Journal of Biological Chemistry.

[37]  S. Stringer,et al.  Functional abnormalities of heparan sulfate in mucopolysaccharidosis-I are associated with defective biologic activity of FGF-2 on human multipotent progenitor cells. , 2005, Blood.

[38]  M. Philips Sef: a MEK/ERK catcher on the Golgi. , 2004, Molecular cell.

[39]  Y. C. Lee,et al.  Characterization and expression of human bifunctional 3'-phosphoadenosine 5'-phosphosulphate synthase isoforms. , 2002, The Biochemical journal.

[40]  H. Kitagawa,et al.  Human tumor suppressor EXT gene family members EXTL1 and EXTL3 encode α1,4- N-acetylglucosaminyltransferases that likely are involved in heparan sulfate/ heparin biosynthesis , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[41]  T. Shirasawa,et al.  Association of EXT1 and EXT2, hereditary multiple exostoses gene products, in Golgi apparatus. , 2000, Biochemical and biophysical research communications.

[42]  M. Yanagishita,et al.  Differential effect of brefeldin A on the biosynthesis of heparan sulfate and chondroitin/dermatan sulfate proteoglycans in rat ovarian granulosa cells in culture. , 1993, The Journal of biological chemistry.

[43]  J. Hopwood,et al.  Lysosomal degradation of heparin and heparan sulphate. , 1992, Advances in experimental medicine and biology.

[44]  B. Geiger,et al.  Immunocytochemical localization of native chondroitin-sulfate in tissues and cultured cells using specific monoclonal antibody , 1984, Cell.